# Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

> **NCT06402318** · — · RECRUITING · sponsor: **The Geneva Foundation** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19
- SARS CoV 2 Virus
- COVID-19 Pneumonia
- COVID-19 Respiratory Infection
- COVID-19 Acute Respiratory Distress Syndrome

## Interventions

- **DEVICE:** A&M Breathalyzer PROTECT Kiosk

## Key facts

- **NCT ID:** NCT06402318
- **Lead sponsor:** The Geneva Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-27
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- Brooke Army Medical Center
- Uniformed Services University of the Health Sciences
- Level 42 AI, Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06402318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06402318, "Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT06402318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*